UDP-glucuronate metabolism controls RIPK1-driven liver damage in nonalcoholic steatohepatitis

Abstract Hepatocyte apoptosis plays an essential role in the progression of nonalcoholic steatohepatitis (NASH). However, the molecular mechanisms underlying hepatocyte apoptosis remain unclear. Here, we identify UDP-glucose 6-dehydrogenase (UGDH) as a suppressor of NASH-associated liver damage by i...

Full description

Bibliographic Details
Main Authors: Tao Zhang, Na Zhang, Jing Xing, Shuhua Zhang, Yulu Chen, Daichao Xu, Jinyang Gu
Format: Article
Language:English
Published: Nature Portfolio 2023-05-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-38371-2
_version_ 1797827448608391168
author Tao Zhang
Na Zhang
Jing Xing
Shuhua Zhang
Yulu Chen
Daichao Xu
Jinyang Gu
author_facet Tao Zhang
Na Zhang
Jing Xing
Shuhua Zhang
Yulu Chen
Daichao Xu
Jinyang Gu
author_sort Tao Zhang
collection DOAJ
description Abstract Hepatocyte apoptosis plays an essential role in the progression of nonalcoholic steatohepatitis (NASH). However, the molecular mechanisms underlying hepatocyte apoptosis remain unclear. Here, we identify UDP-glucose 6-dehydrogenase (UGDH) as a suppressor of NASH-associated liver damage by inhibiting RIPK1 kinase-dependent hepatocyte apoptosis. UGDH is progressively reduced in proportion to NASH severity. UGDH absence from hepatocytes hastens the development of liver damage in male mice with NASH, which is suppressed by RIPK1 kinase-dead knockin mutation. Mechanistically, UGDH suppresses RIPK1 by converting UDP-glucose to UDP-glucuronate, the latter directly binds to the kinase domain of RIPK1 and inhibits its activation. Recovering UDP-glucuronate levels, even after the onset of NASH, improved liver damage. Our findings reveal a role for UGDH and UDP-glucuronate in NASH pathogenesis and uncover a mechanism by which UDP-glucuronate controls hepatocyte apoptosis by targeting RIPK1 kinase, and suggest UDP-glucuronate metabolism as a feasible target for more specific treatment of NASH-associated liver damage.
first_indexed 2024-04-09T12:48:29Z
format Article
id doaj.art-82c7fb2e83e7455d8e70dbc12828b84b
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-04-09T12:48:29Z
publishDate 2023-05-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-82c7fb2e83e7455d8e70dbc12828b84b2023-05-14T11:21:46ZengNature PortfolioNature Communications2041-17232023-05-0114111810.1038/s41467-023-38371-2UDP-glucuronate metabolism controls RIPK1-driven liver damage in nonalcoholic steatohepatitisTao Zhang0Na Zhang1Jing Xing2Shuhua Zhang3Yulu Chen4Daichao Xu5Jinyang Gu6Center for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyInterdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of SciencesLingang LaboratoryCenter for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyInterdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of SciencesInterdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of SciencesCenter for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAbstract Hepatocyte apoptosis plays an essential role in the progression of nonalcoholic steatohepatitis (NASH). However, the molecular mechanisms underlying hepatocyte apoptosis remain unclear. Here, we identify UDP-glucose 6-dehydrogenase (UGDH) as a suppressor of NASH-associated liver damage by inhibiting RIPK1 kinase-dependent hepatocyte apoptosis. UGDH is progressively reduced in proportion to NASH severity. UGDH absence from hepatocytes hastens the development of liver damage in male mice with NASH, which is suppressed by RIPK1 kinase-dead knockin mutation. Mechanistically, UGDH suppresses RIPK1 by converting UDP-glucose to UDP-glucuronate, the latter directly binds to the kinase domain of RIPK1 and inhibits its activation. Recovering UDP-glucuronate levels, even after the onset of NASH, improved liver damage. Our findings reveal a role for UGDH and UDP-glucuronate in NASH pathogenesis and uncover a mechanism by which UDP-glucuronate controls hepatocyte apoptosis by targeting RIPK1 kinase, and suggest UDP-glucuronate metabolism as a feasible target for more specific treatment of NASH-associated liver damage.https://doi.org/10.1038/s41467-023-38371-2
spellingShingle Tao Zhang
Na Zhang
Jing Xing
Shuhua Zhang
Yulu Chen
Daichao Xu
Jinyang Gu
UDP-glucuronate metabolism controls RIPK1-driven liver damage in nonalcoholic steatohepatitis
Nature Communications
title UDP-glucuronate metabolism controls RIPK1-driven liver damage in nonalcoholic steatohepatitis
title_full UDP-glucuronate metabolism controls RIPK1-driven liver damage in nonalcoholic steatohepatitis
title_fullStr UDP-glucuronate metabolism controls RIPK1-driven liver damage in nonalcoholic steatohepatitis
title_full_unstemmed UDP-glucuronate metabolism controls RIPK1-driven liver damage in nonalcoholic steatohepatitis
title_short UDP-glucuronate metabolism controls RIPK1-driven liver damage in nonalcoholic steatohepatitis
title_sort udp glucuronate metabolism controls ripk1 driven liver damage in nonalcoholic steatohepatitis
url https://doi.org/10.1038/s41467-023-38371-2
work_keys_str_mv AT taozhang udpglucuronatemetabolismcontrolsripk1drivenliverdamageinnonalcoholicsteatohepatitis
AT nazhang udpglucuronatemetabolismcontrolsripk1drivenliverdamageinnonalcoholicsteatohepatitis
AT jingxing udpglucuronatemetabolismcontrolsripk1drivenliverdamageinnonalcoholicsteatohepatitis
AT shuhuazhang udpglucuronatemetabolismcontrolsripk1drivenliverdamageinnonalcoholicsteatohepatitis
AT yuluchen udpglucuronatemetabolismcontrolsripk1drivenliverdamageinnonalcoholicsteatohepatitis
AT daichaoxu udpglucuronatemetabolismcontrolsripk1drivenliverdamageinnonalcoholicsteatohepatitis
AT jinyanggu udpglucuronatemetabolismcontrolsripk1drivenliverdamageinnonalcoholicsteatohepatitis